Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TPET | Common Stock | Sale | -$51.7K | -190K | -100% | $0.27 | 0 | Jul 3, 2024 | Direct | |
transaction | TPET | Common Stock | Sale | -$57.3K | -210K | -81.71% | $0.27 | 47K | Jul 3, 2024 | See Footnote | F1 |
Frank C. Ingriselli is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | These shares of common stock were sold pursuant to a 10b5-1 plan, that the reporting person and Brightening Lives Foundation Inc. ("BLF") entered into on March 20, 2024 . Mr. Ingriselli is the Chief Executive Officer of BLF and holds investment and voting control over such shares. The address of BLF is 9000 Crow Canyon Road, Suite 362, Danville, CA 94506. Prior to these sales, BLF held 257,000 shares of common stock of the issuer. Mr. Ingriselli may be deemed to have beneficial ownership of the shares of common stock held by BLF. Mr. Ingriselli disclaims beneficial ownership of the shares of common stock held by BLF reported herein, except to the extent of his pecuniary interest therein. |